Research graph
References from Current approaches and challenges in pediatric neuromuscular blockade monitoring: A scoping review. Local targets link to admitted publications; unresolved targets remain external evidence.
Re evaluation of dosage and duration of action of D tubocurarine in the pediatric age group
10.1097/00000542-197510000-00007 · 1975 · External reference
Characteristics of succinylcholine neuromuscular blockade in neonates
10.1213/00000539-197801000-00011 · 1978 · External reference
Maturation of neuromuscular transmission in the infant
10.1093/bja/52.2.205 · 1980 · External reference
Assessment of neuromuscular function in infants
10.1097/00000542-198101000-00006 · 1981 · External reference
Recovery from pancuronium blockade in the neonatal intensive care unit
10.1093/bja/53.12.1303 · 1981 · External reference
Dose response to intramuscular succinylcholine in children
10.1097/00000542-198111000-00027 · 1981 · External reference
Clinical pharmacology of atracurium in infants
10.1213/00000539-198403000-00005 · 1984 · External reference
Prolonged infusion of suxamethonium in infants and children
10.1093/bja/58.8.839 · 1986 · External reference
Spontaneous-recovery of neuromuscular function after atracurium in pediatric-patients
10.1213/00000539-198610000-00009 · 1986 · External reference
Infusion of atracurium in neonates, infants and children: a study of dose requirements
10.1093/bja/60.6.651 · 1988 · External reference
The potency of pancuronium at the adductor pollicis and diaphragm in infants and children
10.1097/00000542-198806000-00012 · 1988 · External reference
Age-dependence of the dose-response curve of vecuronium in pediatric-patients during balanced anesthesia
10.1213/00000539-198801000-00004 · 1988 · External reference
Post-tetanic count and intense neuromuscular blockade with vecuronium in children
10.1093/bja/61.5.551 · 1988 · External reference
Post-tetanic count and profound neuromuscular blockade with atracurium infusion in paediatric patients
10.1093/bja/60.1.31 · 1988 · External reference
Effect of surface electrode positioning on the compound action potential evoked by ulnar nerve stimulation in anaesthetized infants and children
10.1093/bja/62.2.188 · 1989 · External reference
Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?
10.1093/bja/62.2.184 · 1989 · External reference
Postoperative neuromuscular block following atracurium or alcuronium in children
10.1007/bf03006532 · 1990 · External reference
Dose-response characteristics of pancuronium in neonates, infants and children
10.1177/0310057x9001800406 · 1990 · External reference
Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia
10.1213/00000539-199010000-00007 · 1990 · External reference
Postoperative neuromuscular function in pediatric day-care patients
10.1213/00000539-199104000-00015 · 1991 · External reference
Continuous vecuronium infusion for prolonged muscle relaxation in children
10.1007/bf03008139 · 1991 · External reference
Pharmacodynamic and hemodynamic effects of mivacurium in infants anesthetized with halothane and nitrous oxide
10.1097/00000542-199311000-00008 · 1993 · External reference
Pharmacodynamics of mivacurium in children, using a computer-controlled infusion
10.1093/bja/71.2.232 · 1993 · External reference
Vecuronium infusion requirements in pediatric-patients in intensive-care units and the use of acceleromyography
1995 · External reference
Assessment of neuromuscular block at the thumb and great toe using accelography in infants
10.1111/j.1365-2044.1996.tb07744.x · 1996 · External reference
Does age or pseudocholinesterase activity predict mivacurium infusion rate in children?
1996 · External reference
Dose-response and minimum time to satisfactory intubation conditions after mivacurium in children
10.1111/j.1365-2044.1996.tb07787.x · 1996 · External reference
Continuous infusion of rocuronium in a paediatric intensive care unit
10.1007/bf03011713 · 1996 · External reference
Monitoring orbicularis oculi predicts good intubating conditions after vecuronium in children
10.1007/bf03013383 · 1997 · External reference
A prospective evaluation of the continuous infusion of cis-atracurium for neuromuscular blockade in the pediatric intensive care unit patient: efficacy and dosage requirements
10.1097/00045391-199709000-00002 · 1997 · External reference
The pharmacokinetics and steady state pharmacodynamics of mivacurium in children
10.1097/00000542-199804000-00018 · 1998 · External reference
The time-course of action and recovery of rocuronium 0.3 Mg · Kg-1 in infants and children during halothane anaesthesia measured with acceleromyography
10.1046/j.1460-9592.2000.00543.x · 2000 · External reference
A dose-ranging study of rapacuronium in pediatric patients
10.1097/00000542-200004000-00017 · 2000 · External reference
Duration of action of atracurium when given by infusion to critically ill children
10.1046/j.1460-9592.2000.00436.x · 2000 · External reference
The effect of induced hypothermia on the duration of action of atracurium when given by infusion to critically ill children
10.1046/j.1460-9592.2000.00437.x · 2000 · External reference
Dose-response relationship and infusion requirement of cisatracurium besylate in infants and children during nitrous oxide-narcotic anesthesia
10.1097/00000542-200105000-00016 · 2001 · External reference
10.1186/1471-2253-1-1 · 2001 · Admitted local publication
Neuromuscular blocking agents in critically iii children
10.1185/146300902322125145 · 2002 · External reference
Comparison of cisatracurium and vecuronium by infusion in neonates and small infants after congenital heart surgery
10.1097/00000542-200411000-00011 · 2004 · External reference
Neuromuscular transmission monitoring in children
10.1046/j.1460-9592.2003.01152.x · 2004 · External reference
Pediatric-compatible train-of-four monitoring
10.1111/j.1460-9592.2005.01682.x · 2005 · External reference
Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit
10.1007/s00134-005-2615-3 · 2005 · External reference
Pharmacokinetics and pharmacodynamics of a 0.1 mg/kg dose of cisatracurium besylate in children during N2o/O2/propofol anesthesia
10.1213/01.ane.0000195342.29133.ce · 2006 · External reference
Priming with rocuronium accelerates neuromuscular block in children: a prospective randomized study
10.1007/bf03022317 · 2007 · External reference
The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery
10.1007/s00134-008-1252-z · 2008 · External reference
Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients
10.1097/aln.0b013e318194caaa · 2009 · External reference
The pharmacology of anaesthetics in the neonate
10.1016/j.bpa.2010.02.019 · 2010 · External reference
Chapter 4 Acceleromyography
2010 · External reference
Comparison of intubating conditions of succinylcholine with two doses of rocuronium bromide in children
10.4103/0970-9185.74682 · 2010 · External reference
Neuromuscular block and current treatment strategies for its reversal in children
10.1111/j.1460-9592.2010.03335.x · 2010 · External reference
Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube
10.1016/s0034-7094(11)70019-8 · 2011 · External reference
Continuous-infusion neuromuscular blocking agents in critically ill neonates and children
10.1592/phco.31.6.609 · 2011 · External reference
Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children
10.1111/j.1460-9592.2010.03514.x · 2011 · External reference
Time course of rocuronium-induced neuromuscular blockade in pediatric patients: a phase III, randomized, dose-response study
10.4172/2155-6148.1000189 · 2012 · External reference
The characteristics of the staircase phenomenon during the period of twitch stabilization in infants in Tof mode
10.1111/pan.12041 · 2013 · External reference
Limited professional guidance and literature are available to guide the safe use of neuromuscular block in infants
10.1111/apa.12682 · 2014 · External reference
The efficacy and safety of mivacurium in pediatric patients
10.1186/s12871-017-0350-2 · 2017 · External reference
Pharmacodynamics of cisatracurium in adults and children undergoing living donor liver transplantation
2017 · External reference
Reversibility of rocuronium-induced deep neuromuscular block with sugammadex in infants and children—a randomized study
10.1248/bpb.b19-00044 · 2019 · External reference
Effects of high neuromuscular blocking agent dose on post-operative respiratory complications in infants and children
10.1111/aas.13478 · 2020 · External reference
Neurophysiological assessment of prolonged recovery from neuromuscular blockade in the neonatal intensive care unit
10.3389/fped.2020.00580 · 2020 · External reference
Shortening of the twitch stabilization period by tetanic stimulation in acceleromyography in infants, children and young adults (Ststs-study): a prospective randomised, controlled trial
10.1007/s10877-019-00435-4 · 2020 · External reference
Incidence of residual neuromuscular blockade in children below 3 years after a single bolus of cisatracurium 0.1 mg/kg: a quality assurance study
10.1111/aas.13495 · 2020 · External reference
Management of neuromuscular block in pediatric patients — safety implications
10.1007/s40140-022-00537-x · 2022 · External reference
Anesthesia and ancillary drugs and the neonate
2023 · External reference
A retrospective observational cross-sectional study of intraoperative neuromuscular blocking agent choice and dosing in a US paediatric referral hospital before and after introduction of sugammadex☆
10.1016/j.bja.2023.07.013 · 2023 · External reference
Good clinical research practice (Gcrp) in pharmacodynamic studies of neuromuscular blocking agents III: the 2023 Geneva revision
10.1111/aas.14279 · 2023 · External reference
Intraoperative electromyographic monitoring in children using a novel pediatric sensor
10.4103/sja.sja_160_23 · 2023 · External reference
Reversal of rocuronium induced neuromuscular block with sugammadex in patients under 2 years of age. A series of 280 cases
2023 · External reference
Airway management in neonates and infants: European society of anaesthesiology and intensive care and British Journal of Anaesthesia joint guidelines
10.1016/j.bja.2023.08.040 · 2024 · External reference
Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age
10.1111/pan.14773 · 2024 · External reference
Recurarisation after sugammadex in children: review of case reports and recommendations
10.1016/j.bja.2023.09.028 · 2024 · External reference
Pediatric intraoperative electromyographic responses at the adductor pollicis and flexor hallucis brevis muscles: a prospective, comparative analysis anesthesia and analgesia
2024 · External reference
Neuromuscular blockade monitoring in pediatric patients
10.17085/apm.23158 · 2024 · External reference
Spontaneous recovery from neuromuscular block after a single dose of a muscle relaxant in pediatric patients: a systematic review using a network meta-analytic and meta-regression approach
10.1111/pan.14908 · 2024 · External reference
